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INTRODUCTION
Upstream stimulatory factor 1 (USF1) is a transcription
factor belonging to the basic helix-loop-helix leucine zipper
family. It is known to regulate the expression of several genes
involved in glucose (1) and lipid metabolism, such as those
encoding apolipoproteins (2, 3), hepatic lipase (4), and glu-
cokinase (5) in the liver and fatty acid synthase (6), acetyl-
CoA carboxylase (7), and hormone-sensitive lipase (8) in the
adipose tissue.
The upstream transcription factor 1 (USF1) gene is locat-
ed on chromosome 1q22-23. In linkage studies, it was found
to colocalize with the familial combined hyperlipidemia
(FCHL) and type 2 diabetes loci (9, 10). USF1 polymorphism
is reported to be associated with FCHL in Finnish (9) and
Mexican families (11). There are several studies on the asso-
ciation between USF1 and metabolic abnormalities, such as
hyperlipidemia, diabetes, and cardiovascular disease, in var-
ious populations (9-15). However, the association between
USF1 and metabolic abnormalities remains debatable.
In a study involving the European population (15), the two
common USF1 single nucleotide polymorphisms (SNPs),
rs2073653 (306A>G) and rs2516840 (1748C>T), showed
an association with the effect of body mass index (BMI) on
low-density lipoprotein (LDL) cholesterol levels only in young
males whose fathers had a proven myocardial infarction before
the age of 55 yr but not in the controls who were age-match-
ed and recruited irrespective of family history. In Korean pop-
ulation, no study on the association between USF1 SNPs
and dyslipidemia or BMI has been performed.
In the present study, we attempted to examine the associ-
ation between USF1 SNPs and dyslipidemia or BMI in the
general Korean population. Therefore, we selected two com-
mon USF1 SNPs (rs2073653 and rs2516840) that showed
an association with the effect of BMI on LDL cholesterol levels
in the European Atherosclerosis Research Study II (15). Fur-
thermore, we divided the subjects into 3 groups (premeno-
pausal females, postmenopausal females, and males) due to
the different levels of obesity and blood lipids by gender
(female vs. male) and menopausal state (17-19).
MATERIALS AND METHODS
Subjects
From January 2003 to April 2004, 275 Korean adults were
recruited at the Eulji University Hospital, and ethics approval
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Body Mass Index is Associated with USF1 Haplotype in Korean 
Premenopausal Women
The upstream stimulatory factor 1 (USF1) gene has been shown to play an essen-
tial role as the cause of familial combined hyperlipidemia, and there are several asso-
ciation studies on the relationship between USF1 and metabolic disorders. In this
study, we analyzed two single nucleotide polymorphisms in USF1 rs2073653 (306A>
G) and rs2516840 (1748C>T) between the case (dyslipidemia or obesity) group
and the control group in premenopausal females, postmenopausal females, and
males among 275 Korean subjects. We observed a statistically significant differ-
ence in the GC haplotype between body mass index (BMI) ≥ ≥25 kg/m
2 and BMI
<25 kg/m
2 groups in premenopausal females (
2=4.23, p=0.04). It seems that the
USF1 GC haplotype is associated with BMI in premenopausal Korean females. 
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Of the subjects, 139 were premenopausal females; 76 were
postmenopausal females; and 60 were males. The mean ages
of the pre- and postmenopausal females were 40 (range, 33-
47 yr) and 60 yr (range, 54-66 yr), respectively. The mean
age of the male subjects was 41 (range, 28-54 yr). None of
the subjects had renal or liver disease, diabetes, or cardiovas-
cular disease, except hypertension. None of them was taking
medication that could affect blood lipid, glucose, or thyroid
metabolism or obesity. Based on their menstrual history, all
the postmenopausal females had no menstrual bleeding for
more than 1 yr. They all had undergone menopause natural-
ly and were taking neither estrogen nor estrogen and pro-
gestin combined pills. The clinical profiles of the subjects
are summarized in Table 1.
We divided the subjects into 3 groups (pre- and postmeno-
pausal females, and males) for analysis. To perform a case-con-
trol study by using the chi-square test including genotypic,
allelic, and haplotype frequencies, the subjects were divided
into the case and control groups for each parameter (BMI,
total blood cholesterol, LDL cholesterol, triglycerides, and
high-density lipoprotein (HDL) cholesterol levels). The lipid
levels of the subjects in the control group were as follows.
Total blood cholesterol <200 mg/dL, LDL cholesterol <100
mg/dL, triglycerides <150 mg/dL, and HDL cholesterol ≥
40 mg/dL in males and 50 mg/dL in females. The BMI level
of the subjects in the control group was <25 kg/m2. The lipid
levels of the subjects in the case group were as follows: total
blood cholesterol ≥200 mg/dL, LDL cholesterol ≥100 mg/
dL, triglycerides ≥150 mg/dL, and HDL cholesterol <40
mg/dL in males and 50 mg/dL in females. The BMI level of
the subjects in the case group was ≥25 kg/m2. 
Measurements
Anthropometric parameters, including body weight, height,
and waist circumference, were measured in all the subjects.
BMI was calculated as the weight divided by the square of
the height (kg/m
2). The circumference of the waist was mea-
sured midway between the margin of the lower rib and the
iliac crest. Blood pressure was measured after the subjects sat
in a chair for at least 10 min. Measurements were performed
at the Eulji University Hospital clinical laboratory. Follow-
ing a 12-hr overnight fast, a blood sample was collected in
the morning for the assessment of blood biochemistry and
lipid levels and for genotyping. By using routine laboratory
techniques, the levels of total cholesterol, triglycerides, HDL
cholesterol, and LDL cholesterol were measured from serum
samples.
Genotyping
Blood was collected from the subjects by venipuncture and
stored in EDTA Vacutainer tubes at -70℃. DNA was ex-
tracted using a G-spin Genomic DNA Extraction Kit (iNt-
Ron, Daejeon, Korea). We examined the two USF1 polymor-
phisms, rs2073653 (306A>G) and rs2516840 (1748C>T),
as described previously (15). We designed specific primers
as following sequences; 5′ -CAGCTTCTGTTGGGAATG-
CCG-3′and 5′ -AAAAGACGACGGACAAACACCA-3′
for rs2073653 genotyping, and 5′ -GGCTGAAAGGGC-
TAGAATAGG-3′and 5′ -CCTGGTCCCCTCCTCTAA-
AA-3′for rs2516840 genotyping. Polymerase chain reac-
tion (PCR) was performed in a 40  L reaction volume com-
prising 50 mM Tris (pH 8.3), 16 mM (NH4)2SO4, 1.75 mM
MgCl2, 2.5 mM of each dNTP, 2 U HiPi thermostable DNA
polymerase (Elpis-Biotech Inc., Daejeon, Korea), 0.6  g geno-
mic DNA, and 10 pM of specific primers. Amplification was
performed in a MBS 0.2G thermocycler (Thermo Electron
Corporation, Waltham, MA, U.S.A.). For rs2073653 geno-
typing, PCR was carried out at 95℃ for 10 min, followed
by 30 cycles at 95℃ for 30 sec, 58℃ for 30 sec, and 72℃
for 30 sec. Final extension was done at 72℃for 10 min. And
for rs2516840 genotyping, PCR was performed at 95℃ for
10 min, followed by 30 cycles at 95℃ for 45 sec, 58℃ for
45 sec, and 72℃for 45 sec. Final extension was done at 72℃
for 10 min. The amplified products were electrophoresed on
a 2% agarose gel in 0.5×TBE running buffer and were visu-
alized using ethidium bromide for size estimation. Each PCR
product was incubated with 1 U restriction enzyme (MspI)
for 20 hr. The restricted fragments were electrophoresed on
a 3.5% agarose gel in 0.5×TBE running buffer and were
visualized using ethidium bromide.
Statistical analysis 
Chi-square tests were performed to estimate the Hardy-
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Premenopa- 
usal female
(n=139)
Postmenopa-
usal female
(n=76)
Male
(n=60)
Age (yr) 40±7
� ,� 60±6
� ,‖ 41±13
BMI (kg/m
2) 22.5±2.7
� ,� ,� 25.5±3.7
� ,‖ 24.0±3.5
Waist circumference (cm) 73.8±7.4
� ,� ,� 84.0±8.6 84.4±9.1
Systolic BP (mmHg) 118±16
� ,� ,� 142±20
� ,‖ 128±15
Diastolic BP (mmHg) 69±11
� ,� ,� 81±12
� ,‖ 75±10
Total cholesterol (mg/dL) 185±32
� ,� 215±41
� ,‖ 186±34
LDL cholesterol (mg/dL) 111±29
� ,� 137±41
� ,‖ 114±27
HDL cholesterol (mg/dL) 55±11*
,� 52±12 51±10
Triglyceride (mg/dL) 99±67
� ,� 132±85 106±64
Fasting blood glucose (mg/dL) 84±8
� ,� ,� 92±12
� ,‖ 88±9
Table 1. Clinical characteristics of study subjects
Data were shown as mean±standard deviation (SD). Analysis of vari-
ance (ANOVA) test was done among 3 groups. *, p<0.05; 
� , p<0.01; 
� ,
between premenopausal and postmenopausal female; 
�, between pre-
menopausal female and male; 
‖, between postmenopausal female and
male. 
BMI, body mass index; BP, blood pressure; LDL, low-density lipoprotein;
HDL, high-density lipoprotein.Weinberg equilibrium in all 3 groups. In linkage disequi-
librium (LD) tests, the values of the LD coefficient (D′ ) and
squared correlation coefficient (r
2) were calculated. To test
the allelic and genotypic differences among the phenotypes
in the pre- and postmenopausal female groups and the male
group, a case-control association study was performed using
the chi-square test. The haplotype frequencies and the differ-
ences in the haplotype distribution were examined. All these
tests were conducted using SNPAlyze 5.0.4 (Dynacom, Chiba,
Japan). In addition, we examined the differences in age, BMI,
fasting blood glucose levels, and blood lipid levels (as contin-
uous variables) among the rs2073653 and rs2516840 geno-
types via analysis of variance (ANOVA) or the Student t-test
by using the Statistical Package for the Social Sciences soft-
ware (SPSS, Korean version 12.0). The related data were rep-
resented as mean±standard deviation (SD). p<0.05 was con-
sidered to be statistically significant.
RESULTS
To investigate the relationship between USF1 SNPs and
dyslipidemia or obesity, we divided the subjects into 3 groups
comprising premenopausal females (n=139), postmenopausal
females (n=76), and males (n=60). As shown in Table 1, these
3 groups exhibited different clinical characteristics depend-
ing on the gender and menopausal state. Postmenopausal
females have increased BMI, waist circumference, blood pres-
sure, and levels of total cholesterol, LDL cholesterol, triglyc-
erides, and fasting blood glucose, compared to premenopausal
females. In this study, compared to the males who were of a
similar age as the premenopausal females, the postmenopausal
females showed increases in most parameters, except waist
circumference, levels of HDL cholesterol and triglycerides.
Compared to the premenopausal females, the male subjects
had increased BMI, waist circumference, blood pressure, and
fasting blood glucose but decreased HDL cholesterol levels. 
The genotypic and haplotype frequencies and the LD bet-
ween rs2073653 and rs2516840 are shown in Table 2. In all
the subjects, the frequencies of the minor alleles of rs2073653
and rs2516840 were 0.48 (A allele) and 0.14 (T allele). In
all 3 groups, the genotypic distribution did not deviate from
the Hardy-Weinberg equilibrium for the two polymorphisms
(data not shown). LD analysis revealed a D′ value of higher
than 0.5 but not higher than 0.25 at the r
2 between the two
polymorphisms in all 3 groups. We also estimated 4 haplo-
types and their frequencies. The frequencies of the haplotypes
were 0.52 (GC), 0.34 (AC), 0.14 (AT), and 0.01 (GT). 
As continuous variables, we analyzed the age, BMI, and
levels of fasting blood glucose and lipids such as total choles-
terol, LDL cholesterol, HDL cholesterol, and triglycerides
according to the genotypes of rs2073653 and rs2516840
(Table 3). For 3 genotypes of rs2073653, the results did not
reveal any statistically significant differences in the analyzed
factors in all 3 groups. Because the TT genotype in rs2516840
is rare, we analyzed only two genotypes (CC and CT) of rs-
2516840 by using the Student t-test. For this SNP site, we
could not detect any statistically significant difference in the
analyzed factors in all 3 groups (Table 3).
In the case-control analysis, there was no significant differ-
ence in the genotypic or allelic frequencies for rs2073653 or
rs2516840 between the case and control groups, which were
divided based on the BMI, and the levels of total cholesterol,
triglycerides, LDL cholesterol, and HDL cholesterol, in any
of the 3 groups (Table 4). 
The GC haplotype for rs2073653 and rs2516840 revealed
a significant difference between the case (BMI ≥25 kg/m2;
n=22) and control (BMI <25 kg/m2; n=117) groups among
the premenopausal females (
2=4.23, p=0.04); however, there
was no association of the other haplotypes between the case
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All (%) Premenopausal female (%) Postmenopausal female (%) Male (%)
rs2073653 GG 70 (20.73) 41 (29.50) 16 (21.05) 13 (21.67)
GA 148 (53.82) 70 (50.36) 45 (59.21) 33 (55.00)
AA 57 (25.45) 28 (20.14) 15 (19.74) 14 (23.33)
G 0.52 0.55 0.51 0.49
A 0.48 0.45 0.49 0.51
rs2516840 CC 200 (72.73) 101 (73.66) 57 (75.00) 42 (70.00)
CT 72 (26.18) 36 (25.89) 19 (25.00) 17 (28.33)
TT 3 (1.09) 2 (1.45) 0 (0.00) 1 (1.67)
C 0.86 0.86  0.88  0.93 
T 0.14 0.14  0.12  0.07 
Haplotype frequency GC 0.52  0.54  0.51  0.49 
AC 0.34 0.32  0.37  0.35 
AT 0.14 0.13  0.13  0.16 
GT 0.01 0.01  0.00  0.00 
Linkage disequilibrium D′ 0.92 0.87  1.00  1.00 
r
2 0.16 0.15  0.15  0.18 
Table 2. Frequencies of genotype and haplotype, and linkage disequilibrium in the subjects
Haplotypes were constructed with rs2073653+rs2516840.and control groups (Table 5) and no association between the
GC haplotype and the lipid levels in the premenopausal females
(Table 6). In the postmenopausal female group and the male
group, the frequencies of all the haplotypes were not signifi-
cantly different between the case and control groups in terms
of the BMI, as well as in the lipid levels (Table 6).
DISCUSSION
In the present study, we recruited subjects based on the
population to which they belonged; the subjects were with-
out coronary heart disease, ischemic stroke, type 2 diabetes
mellitus, renal disease, or liver disease. We attempted to inves-
tigate an association between the USF1 SNPs and BMI or
blood lipid levels. 
It is known that the USF1 polymorphisms rs2073653 and
rs2516840 demonstrate ethnic differences with regard to their
genotypic and allelic frequencies among populations (http://
www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2073653, http://
www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2516840). In
this study, the minor allelic frequencies of rs2073653 and
rs2516840 were found to be 0.48 and 0.14, respectively; how-
ever, for the Caucasian population, these frequencies have been
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Premenopausal female
Genotype rs2073653
GG GA AA
rs2516840
CC CT TT
Male
rs2073653
GG GA AA
rs2516840
CC CT TT
Postmeonopausal female
rs2073653
GG GA AA
rs2516840
CC CT
Number 41 70 28 101 36 2 16 45 15 57 19 13 33 14 42 17 1
Age (yr) 39 41 40 40 40 42 58 61 61 60 62 39 42 43 41 42 27
±6 ±8 ±6 ±7 ±6 ±8 ±5 ±5 ±7 ±6 ±6 ±10 ±15 ±13 ±13 ±14
BMI (kg/m
2) 21.8 22.7 22.8 22.4 22.4 24.3 25.9 25.7 24.7 25.4 25.9 24.0 23.8 24.6 24.2 24.0 20
±2.4 ±2.9 ±2.2 ±2.5 ±3.0 ±0.8 ±4.3 ±4.0 ±1.9 ±3.6 ±4.0 ±2.3 ±3.9 ±3.7 ±3.6 ±3.4
Total chole- 184 184 189 187 182 170 231 212 207 219 204 187 183 193 188 185 139
sterol (mg/dL) ±30 ±32 ±36 ±30 ±37 ±22 ±50 ±39 ±32 ±41 ±37 ±21 ±34 ±45 ±28 ±46
LDL choles- 111 111 110 112 108 105 155 134 127 141 123 111 113 122 114 118 75
terol (mg/dL) ±28 ±29 ±32 ±28 ±34 ±15 ±47 ±38 ±41 ±40 ±40 ±19 ±26 ±36 ±23 ±35
HDL choles- 56 53 57 54 55 53 52 53 49 53 50 56 50 47 52 46 50
terol (mg/dL) ±10 ±10 ±12 ±11 ±11 ±1 ±13 ±12 ±10 ±12 ±9 ±14 ±8 ±10 ±10 ±10
TG (mg/dL) 88 102 110 103 91 62 122 130 149 123 158 96 105 117 107 106 69
±48 ±57 ±106 ±74 ±43 ±40 ±59 ±89 ±101 ±63 ±131 ±51 ±73 ±51 ±68 ±55
Fasting blood  83 84 84 84 84 86 93 91 96 92 93 87 87 89 88 87 85
glucose  ±9 ±8 ±7 ±8 ±7 ±6 ±14 ±11 ±14 ±13 ±11 ±11 ±9 ±6 ±9 ±7
(mg/dL)
Table 3. Comparison of phenotypes among genotypes in three groups
Data were shown as mean±standard deviation (SD). Analysis of variance (ANOVA) test was done among 3 genotypes (GG, GA, and AA) of rs2073653,
and Student t-test was done between 2 genotypes (CC and CT) of rs2516840 in each three group. 
BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglyceride.
Premenopausal female
Allele Genotype
p* p
� OR 95% CI
Postmenopausal female
Allele Genotype
p* p
� OR 95% CI
Male
Allele Genotype
p* p
� OR 95% CI
BMI rs2073653 0.19 0.09 0.58 0.30-1.11 0.89 0.89 0.96 0.50-1.82 0.95 0.89 0.95 0.45-2.01
rs2516840 0.41 0.43 0.71 0.30-1.67 0.59 0.62 1.29 0.48-3.47 0.76 0.73 0.83 0.29-2.38
Total rs2073653 0.57 0.33 0.77 0.46-1.30 0.16 0.09 0.56 0.28-1.10 0.77 0.50 1.31 0.60-2.87
cholesterol rs2516840 0.67 0.64 1.20 0.56-2.59 0.93 0.93 0.96 0.35-2.60 0.71 0.87 1.09 0.38-3.14
Triglyceride rs2073653 0.95 0.79 0.91 0.46-1.80 0.31 0.22 0.63 0.30-1.33 0.68 0.47 1.35 0.60-3.04
rs2516840 0.73 0.47 1.50 0.50-4.48 0.88 0.89 0.92 0.31-2.76 0.80 0.97 0.98 0.32-2.98
LDL cholesterol rs2073653 0.84 0.85 1.05 0.65-1.69 0.57 0.64 0.81 0.33-2.00 0.83 0.61 0.82 0.38-1.76
rs2516840 0.85 0.58 0.83 0.42-1.62 0.36 0.40 0.60 0.18-2.00 0.33 0.60 1.32 0.47-3.67
HDL cholesterol rs2073653 0.67 0.57 1.16 0.70-1.93 0.89 0.89 0.96 0.50-1.82 0.51 0.64 1.29 0.45-3.71
rs2516840 0.49 0.31 1.48 0.69-3.18 1.00 1.00 1.00 0.38-2.65 0.33 0.28 1.98 0.56-6.95
Table 4. Statistical analysis results of frequencies of genotype and allele between case and control groups of each phenotype in three
groups
p*, p value (df=2); p
� , p value (df=1). OR, the ratio of odds for the minor allele of each SNP (A allele in rs2073653 and T allele in rs2516840) in the con-
trol group to the odds for the major allele. CI, confidence interval; BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.published as lower than 0.15 and higher than 0.29, respec-
tively (15). Therefore, these polymorphisms may be useful
in determining the ethnic differences in the USF1 gene func-
tion. This is the first report of a study on USF1 polymor-
phisms in a Korean population.
It is well-known that females become substantially obese
and dyslipidemic after menopause (17-19). As shown in
Table 1, the 3 groups in this study exhibited different levels
of obesity, blood pressure, and blood lipid levels due to dif-
ferences in gender (female vs. male) and menopausal state
(premenopause vs. postmenopause). These data are consis-
tent with those presented in previous reports (17-19). How-
ever, in previous USF1 association studies (12-14), the female
subjects were not divided into subgroups based on their
menopausal state. Therefore, in this study, we examined the
association of USF1 SNPs with BMI and with blood lipid
levels in 3 different groups (pre- and postmenopausal females,
and males). 
Several previous studies regarding the association between
USF1 and metabolic disorders, such as hyperlipidemia and
type 2 diabetes mellitus, have been performed in subjects ascer-
tained for these traits, e.g., FCHL studies involving Finnish
and Mexican families and a type 2 diabetes study involving
Chinese families (9, 11, 13). The present study is population-
based and not family-based.
A French Caucasian population case-control study has
reported the absence of an association with regard to geno-
type and haplotype between 8 USF1 SNPs (rs3516837,
rs1556259, rs2516838, rs2073653, rs2774276, rs2516841,
rs2073658, and rs3737787) and type 2 diabetes (12). It also
reported that USF1 SNPs were not associated with the plas-
ma levels of glucose and lipids in normoglycemic subjects
(12). A Chinese study reported that USF1 SNPs (rs3737787,
rs2516841, and rs2516839) and haplotype were associated
with type 2 diabetes mellitus in family-based cases; howev-
er, there was no such association in population-based type 2
diabetic cases (13). In addition, this Chinese study reported
that the USF1 haplotype was not associated with blood lipid
levels in family-based cases (13). These results were consis-
tent with the negative association result between USF1 SNPs
and blood lipid levels or fasting blood glucose levels obtained
in this study. 
Our Korean population-based subjects demonstrated no
association between USF1 SNPs (rs2073653 and rs2516840)
and BMI, lipid levels, or fasting blood glucose levels. How-
ever, the occurrence of the GC haplotype with rs2073653
and rs2516840 differed significantly between the case (BMI
≥25 kg/m2) and control (BMI <25 kg/m2) subjects among
the premenopausal females but not among the postmenopau-
sal females and males.
Komulainen et al. reported that USF1 SNPs such as rs-
2516839 was associated with BMI in females with coronary
heart disease or ischemic stroke but not in males and the
subcohort normal control females (14). In the present study,
we did not investigate this SNP rs2516839. It will be need-
ed to examine the association between USF1 SNP rs2516839
and BMI in our study subjects. Komulainen et al. implied a
female-specific risk effect of USF1 and studies for the sex-spe-
cific cardiovascular disease risk genes in different populations
(14). There has also been a report that in MCF-7 breast can-
cer cells, USF1 and the estrogen receptor (ER) alpha may
interact at the ER alpha minimal promoter as components
of a multi-protein complex of transcription factors (20). These
studies suggest that USF1 might affect estrogen function.
However, the suggestion remains to be verified. 
In conclusion, two common USF1 SNPs (rs2073653 and
rs2516840) are not associated with dyslipidemia or BMI in
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Overall 
(n=139)
BMI <25 
kg/m
2
Group 
(n=117)
BMI ≥25 
kg/m
2
Group 
(n=22)
Chi-
square
p
value*
Global 
p value
(df=3)
Haplo-
type
GC 0.54 0.56 0.39 4.23 0.04  0.06 
AC 0.32 0.30 0.42 2.60 0.11 
AT 0.13 0.13 0.14 0.06 0.81 
GT 0.01 0.01 0.04 3.54 0.06 
Table 5. Haplotype analysis and association with BMI in pre-
menopausal female
Haplotypes were constructed with rs2073653+rs2516840; *Likelihood
ratio test with each haplotype and the others to compare the case (BMI
≥25 kg/m
2) group and the control (BMI <25 kg/m
2) (df=1). 
BMI, body mass index.
Haplotype p*
Premenopausal female
GC AC AT GT
Postmenopausal female
GC AC AT
Male
GC AC AT
BMI 0.04 0.11 0.81 0.06 0.89 0.69 0.62 0.89 0.91 0.73 
Total cholesterol 0.26 0.12 0.48 0.44 0.09 0.09 0.94 0.50  0.56  0.87 
TG 0.89 0.49 0.58 0.50 0.22 0.24 0.89 0.47 0.44 0.97 
LDL cholesterol 0.64 0.36 0.33 0.16 0.64 0.92 0.40 0.61  0.34  0.60 
HDL cholesterol 0.44 0.94 0.47 0.27 0.89 0.89 1.00 0.64  0.74  0.28 
Table 6. Comparison of haplotype frequencies between case and control groups of each phenotype in three groups
Haplotypes were constructed with rs2073653+rs2516840; *Likelihood ratio test with each haplotype and the others to compare the case and the con-
trol (df=1). BMI, body mass index; TG, Triglyceride; LDL, low density lipoprotein; HDL, high density lipoprotein; p, p value.the general Korean population, and we propose that occur-
rence of the USF1 GC haplotype with rs2073653 and rs251-
6840 may be associated with BMI in premenopausal Korean
females and has a female-specific effect. The relatively small
sample size and cross-sectional design should be considered
as limitations of the present study. A prospective study involv-
ing a large number of dyslipidemic and obese subjects that
will investigate other USF1 polymorphisms including rs-
2516839 SNP is required to reveal the association between
USF1 and dyslipidemia or obesity in the Korean population.
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